Jade Biosciences (JBIO) Gains from Investment Securities (2020 - 2025)
Jade Biosciences posted quarterly Gains from Investment Securities of -$735000.0 for Q4 2025, down 425.22% year-on-year from $226000.0 in Q4 2024, and down 244.1% on a QoQ basis from $510051.0 in Q3 2025.
Jade Biosciences (JBIO) has 6 years of Gains from Investment Securities data on file, last reported at -$735000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities fell 425.22% year-over-year to -$735000.0; the trailing twelve-month figure through Dec 2025 stood at -$263000.0 (down 113.58% YoY), and the FY2025 full-year result was $9.7 million, up 306.9% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$735000.0, down from $510051.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $9.3 million in Q2 2025 and bottomed at -$735000.0 in Q4 2025.
- The 5-year median for Gains from Investment Securities is $1.5 million (2022), against an average of $2.3 million.
- The widest annual swing landed in 2023, when Gains from Investment Securities soared 559.09%; it then tumbled 425.22% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $264000.0 in 2021, then soared by 454.92% to $1.5 million in 2022, then tumbled by 97.27% to $40000.0 in 2023, then jumped by 465.0% to $226000.0 in 2024, then sank by 425.22% to -$735000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$735000.0 (Q4 2025), $510051.0 (Q3 2025), and $9.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -735,000.00 |
| Dec 31, 2025 | -735,000.00 |
| Sep 30, 2025 | 510,051.00 |
| Sep 30, 2025 | 510,051.00 |
| Jun 30, 2025 | 9.35 Mn |
| Jun 30, 2025 | 9.35 Mn |
| Mar 31, 2025 | 100,492.00 |
| Mar 31, 2025 | 100,492.00 |
| Dec 31, 2024 | 226,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 206,000.00 |
| Mar 31, 2024 | 206,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 5.24 Mn |
| Sep 30, 2023 | 5.24 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 794,557.00 |
| Sep 30, 2022 | 794,557.00 |
| Jun 30, 2022 | 3.95 Mn |
| Jun 30, 2022 | 3.95 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 264,000.00 |
| Dec 31, 2021 | 264,000.00 |
| Sep 30, 2021 | 2.80 Mn |
| Sep 30, 2021 | 2.80 Mn |
| Jun 30, 2021 | 2.54 Mn |
| Jun 30, 2021 | 2.54 Mn |
| Dec 31, 2020 | 229,105.00 |
| Dec 31, 2020 | 229,105.00 |